U.S., May 16 -- ClinicalTrials.gov registry received information related to the study (NCT07590518) titled 'VR Therapies for IBD' on May 06.
Brief Summary: Through a pilot randomized controlled trial (RCT), the aim is to test the clinical impact and feasibility of a AI-enhanced Virtual Reality (VR) Cognitive Behavioral therapy (CBT) program versus distraction VR among patients with inflammatory bowel disease (IBD) and anxiety. It is hypothesized that using VR/AI CBT may reduce anxiety and IBD symptoms, leading to improved overall physical, psychological, and social functioning when compared to distraction VR.
Study Start Date: June, 2026
Study Type: INTERVENTIONAL
Condition:
Inflammatory Bowel Disease (IBD)
Ulcerative Colitis (UC)
Croh...